無料プレビュー

Revvity, Inc. (RVTY) · New York Stock Exchange

プロフィール

Revvity is a leading provider of health science solutions, technologies, and services spanning discovery to development and diagnosis to cure, with specialized focus on translational multi-omics, biomarker identification, imaging, and diagnostics. The company offers a comprehensive portfolio of reagents, instruments, software, and services across life sciences research and clinical diagnostics. Revvity operates through two reportable segments—Life Sciences and Diagnostics—serving pharmaceutical, biotech, academic, and clinical laboratory customers globally across more than 160 countries.

主要指標

株価: $152.16 (-0.94%)
時価総額: 170億ドル
PER（今期予想）: 28.4
PBR: 2.4
配当利回り: 0.23%
52週レンジ: $81.22 – $166.25
業種: Healthcare / Medical - Diagnostics & Research
上場: New York Stock Exchange
構成銘柄: S&P 500 0.03%

比較会社: TMO Thermo Fisher Scientific Inc.、DHR Danaher Corporation、NTRA Natera, Inc.、A Agilent Technologies, Inc.、IQV IQVIA Holdings Inc.、WAT Waters Corporation、IDXX IDEXX Laboratories, Inc.、ILMN Illumina, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-03 · 更新: 2026-10-08